VNRX

VolitionRx Limited · AMEX · Healthcare · USD · 10-K for 2025, filed 2026-03-31

Figures on this page computed 2026-11-08 12:41 UTC

Last close

0.20USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-31

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001477932-26-001832
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001477932-26-001832
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
The filing itself
-1352.2%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001477932-26-001832
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
The filing itself
-1144.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001477932-26-001832
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001477932-26-001832
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.01 against 0.52 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

2.90x

1.04x

1.14x

1.81x

0.00x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-31

Sales2.90x
Its own average over 7 years, 594.7K.
Profit1.04x
Its own average over 10 years, -22.5M.
Free cash flow1.14x
Its own average over 10 years, -17.3M.
Debt1.81x
Its own average over 10 years, 4.2M.
Price0.00x
Its own average over 11 years, 46. Market data, 2026-11-04

Sales is furthest from its own average, at 2.90 times.

Sales is 2.90 times its own 7-year average; Profit is 1.04 times its own 10-year average; Free cash flow is 1.14 times its own 10-year average; Debt is 1.81 times its own 10-year average; Price is 0.00 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-31

Sales against its own 7-year average2.90
Source
filed
Statement
income
Fiscal year
2025
Accession
0001477932-26-001832
Reported in
USD
The filing itself
Profit against its own 10-year average1.04
Source
filed
Statement
income
Fiscal year
2025
Accession
0001477932-26-001832
Reported in
USD
The filing itself
Free cash flow against its own 10-year average1.14
Source
filed
Statement
income
Fiscal year
2025
Accession
0001477932-26-001832
Reported in
USD
The filing itself
Debt against its own 10-year average1.81
Source
filed
Statement
income
Fiscal year
2025
Accession
0001477932-26-001832
Reported in
USD
The filing itself
Price against its own 11-year average0.004Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD